Posted by Michael Wonder on 11 Aug 2019
Details of Canada's biggest drug pricing overhaul in decades
10 August 2019 - The Canadian government finalized the biggest overhaul to its drug pricing regime since 1987 on Friday, giving new powers to the federal drug price regulator, the Patented Medicine Prices Review Board (PMPRB).
The government has said its aim is to lower prices for patented drugs overall. But the impact on individual drugs, especially the effect of new cost-effectiveness and government budget analyses, will depend on how the PMPRB uses its new powers.
The regulator is still drafting guidelines to describe how it will implement the regulations. It said on Friday that draft guidelines may be published in September.
